Felix Gerhard Maria Dietlein, M.D., Ph.D.
This page shows the publications Felix Dietlein has written about HEK293 Cells.
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma. Cell Rep. 2017 Sep 19; 20(12):2833-2845.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.